Recommendations for the diagnosis and treatment of alpha-1 antitrypsin deficiency

Paulo Henrique Ramos Feitosa1,Maria Vera Cruz de Oliveira Castellano2,Claudia Henrique da Costa,Amanda da Rocha Oliveira Cardoso4,Luiz Fernando Ferreira Pereira5,Frederico Leon Arrabal Fernandes6,Fábio Marcelo Costa7,Manuela Brisot Felisbino8,Alina Faria França de Oliveira9,Jose R Jardim10,Marc Miravitlles11

DOI: https://doi.org/10.36416/1806-3756/e20240235

2024-12-08

Jornal Brasileiro de Pneumologia

Abstract:Alpha-1 antitrypsin deficiency (AATD) is a relatively rare genetic disorder, inherited in an autosomal codominant manner, that results in reduced serum AAT concentrations, with a consequent reduction in antielastase activity in the lungs, as well as an increased risk of diseases such as pulmonary emphysema, liver cirrhosis, and necrotizing panniculitis. It results from different mutations in the SERPINA1 gene, leading to changes in the AAT glycoprotein, which can alter its concentration, conformation, and function. Unfortunately, underdiagnosis is quite common; it is possible that only 10% of cases are diagnosed. The most common deficiency is in the Z variant, and it is estimated that more than 3 million people worldwide have combinations of alleles associated with severe AATD. Serum AAT concentrations should be determined, and allelic variants should be identified by phenotyping or genotyping. Monitoring lung function, especially through spirometry, is essential, because it provides information on the progression of the disease. Although pulmonary densitometry appears to be the most sensitive measure of emphysema progression, it should not be used in routine clinical practice to monitor patients. In general, the treatment is similar to that indicated for patients with COPD not caused by AATD. Exogenous administration of purified human serum-derived AAT is the only specific treatment approved for AATD in nonsmoking patients with severe deficiency (serum AAT concentration of < 57 mg/dL or < 11 μM), with evidence of functional loss above the physiological level.

respiratory system